Indirect evidence suggests that men did not understand or appreciate that the effect of PSA on increasing the chance of prostate cancer diagnosis in and of itself should not always be considered a benefit of screening, because of overdiagnosis. The gene discussed is KLK3; the disease is prostate carcinoma.